<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05626686</url>
  </required_header>
  <id_info>
    <org_study_id>CP352</org_study_id>
    <nct_id>NCT05626686</nct_id>
  </id_info>
  <brief_title>An Exploratory Investigation of the Effects of Single Use vs. Reuse Catheters in Intermittent Catheterization</brief_title>
  <official_title>An Exploratory Investigation of the Effects of Single Use vs. Reuse Catheters in Intermittent Catheterization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coloplast A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coloplast A/S</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall aim of the investigation is to investigate the effect of repeated reuse of&#xD;
      intermittent urinary catheters and to observe the impact of switch from single use to&#xD;
      multiple reuse catheters.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Throughout the investigation, the impact of switch from single use to multiple reuse&#xD;
      catheters will be observed and compared with respect to health-related quality of life&#xD;
      (HR-QoL), satisfaction, perception, and preference in female and male catheter-users, who use&#xD;
      clean intermittent catheterization (CIC) for bladder management.&#xD;
&#xD;
      Furthermore, the investigation intends to identify microbial contamination of reused&#xD;
      catheters and compare proportions to a control single use catheter.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 12, 2022</start_date>
  <completion_date type="Anticipated">March 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>The investigation is designed as an open-labelled, single-arm investigation including subjects currently using single use catheters.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Health-related quality of life (HR-QoL) measured by the intermittent self-catheterization questionnaire, (ISC-Q) index score</measure>
    <time_frame>28 days</time_frame>
    <description>Subjects will complete the questionnaire at inclusion and termination</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>28 days</time_frame>
    <description>Number of Adverse Events during the study</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Intermittent Catheterization Satisfaction (InCaSa) questionnaire score</measure>
    <time_frame>28 days</time_frame>
    <description>Subjects will complete the questionnaire at inclusion and termination</description>
  </other_outcome>
  <other_outcome>
    <measure>Perception questions (evaluated on a 6-point scale)</measure>
    <time_frame>28 days</time_frame>
    <description>Subjects will answer questions at termination</description>
  </other_outcome>
  <other_outcome>
    <measure>Total catheter-associated bacterial count (CFU/mL)</measure>
    <time_frame>28 days</time_frame>
    <description>Lab assessment on all used catheters during the study</description>
  </other_outcome>
  <other_outcome>
    <measure>Number of bacterial-positive catheter samples</measure>
    <time_frame>28 days</time_frame>
    <description>Lab assessment on all used catheters during the study</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Urinary Incontinence</condition>
  <arm_group>
    <arm_group_label>CLINY reusable catheter 28 days</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The investigation is designed as an open-labelled, single-arm investigation, in which the reuse CLINY catheter will be compared to single use catheters at baseline.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CLINY catheter</intervention_name>
    <description>Subjects using a single use catheter for bladder management at inclusion. During the study period, subjects will use the reusable CLINY catheter for 28 test-days</description>
    <arm_group_label>CLINY reusable catheter 28 days</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. ≥18 years of age and has full legal capacity&#xD;
&#xD;
          2. Signed informed consent form&#xD;
&#xD;
          3. Use clean intermittent catheterization to the greatest extent possible (at least three&#xD;
             times daily) for at least the last 1 month prior to inclusion&#xD;
&#xD;
          4. Ability (assessed by the investigator) and willingness to participate in a 4-week&#xD;
             study period with at least three catheterizations a day using the investigational test&#xD;
             product&#xD;
&#xD;
          5. Self-catheterize using a single use hydrophilic coated catheter for at least 1 month&#xD;
             prior to inclusion&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Participation in any other clinical intervention study during this investigation&#xD;
&#xD;
          2. Previous participation in this investigation&#xD;
&#xD;
          3. Any known allergies towards ingredients in the investigational device&#xD;
&#xD;
          4. Symptoms of UTI at time of inclusion, as judged by the investigator&#xD;
&#xD;
          5. Antibiotic treatment within 2 weeks prior to the Baseline visit (V1)&#xD;
&#xD;
          6. Pregnancy&#xD;
&#xD;
          7. Breastfeeding&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karin Andersen</last_name>
    <role>Principal Investigator</role>
    <affiliation>Odense Universitetshospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nessn Azawi</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zealand University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Brian Kloster</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ålborg Universitetshospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Katja Bergenholtz</last_name>
    <phone>+4549112159</phone>
    <email>DKKABE@coloplast.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie Louise Mohr</last_name>
    <phone>+4549113506</phone>
    <email>DKMLOM@coloplast.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Odense Universitetshospital</name>
      <address>
        <city>Odense</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karin Andersen</last_name>
      <phone>+4521570468</phone>
      <email>karin.andersen@rsyd.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>January 2023</verification_date>
  <study_first_submitted>August 25, 2022</study_first_submitted>
  <study_first_submitted_qc>November 15, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 25, 2022</study_first_posted>
  <last_update_submitted>January 13, 2023</last_update_submitted>
  <last_update_submitted_qc>January 13, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">January 17, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

